These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 17899837)

  • 1. [Lipoprotein glomerulopathy].
    Saito T
    Nihon Jinzo Gakkai Shi; 2007; Suppl 50th Ann():112-6. PubMed ID: 17899837
    [No Abstract]   [Full Text] [Related]  

  • 2. A new apolipoprotein E mutation, apoE Las Vegas, in a European-American with lipoprotein glomerulopathy.
    Bomback AS; Song H; D'Agati VD; Cohen SD; Neal A; Appel GB; Rovin BH
    Nephrol Dial Transplant; 2010 Oct; 25(10):3442-6. PubMed ID: 20624773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Physiopathology of lipoprotein glomerulopathy].
    Saito T
    Nihon Naika Gakkai Zasshi; 2006 Sep; 95(9):1838-44. PubMed ID: 17037324
    [No Abstract]   [Full Text] [Related]  

  • 4. [Lipoprotein glomerulopathy].
    Oikawa S
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():353-60. PubMed ID: 11347095
    [No Abstract]   [Full Text] [Related]  

  • 5. A novel apolipoprotein E mutation, ApoE Tsukuba (Arg 114 Cys), in lipoprotein glomerulopathy.
    Hagiwara M; Yamagata K; Matsunaga T; Arakawa Y; Usui J; Shimizu Y; Aita K; Nagata M; Koyama A; Zhang B; Mastunaga A; Saku K; Saito T
    Nephrol Dial Transplant; 2008 Jan; 23(1):381-4. PubMed ID: 17967799
    [No Abstract]   [Full Text] [Related]  

  • 6. Impact of lipoprotein glomerulopathy on the relationship between lipids and renal diseases.
    Saito T; Matsunaga A; Oikawa S
    Am J Kidney Dis; 2006 Feb; 47(2):199-211. PubMed ID: 16431249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal lipoprotein and apolipoprotein pattern in lipoprotein glomerulopathy.
    Oikawa S; Suzuki N; Sakuma E; Saito T; Namai K; Kotake H; Fujii Y; Toyota T
    Am J Kidney Dis; 1991 Nov; 18(5):553-8. PubMed ID: 1951334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of a novel apolipoprotein E variant, ApoE Osaka/Kurashiki, in lipoprotein glomerulopathy.
    Saito T; Matsunaga A
    J Atheroscler Thromb; 2011; 18(6):542-3. PubMed ID: 21670560
    [No Abstract]   [Full Text] [Related]  

  • 9. Genetics of type III hyperlipoproteinemia.
    Feussner G; Piesch S; Dobmeyer J; Fischer C
    Genet Epidemiol; 1997; 14(3):283-97. PubMed ID: 9181357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein glomerulopathy: first report of 2 not consanguineous Italian men from the same town.
    Pasquariello A; Pasquariello G; Innocenti M; Minnei F; Funel N; Lorusso P; Barsotti G
    J Nephrol; 2011; 24(3):381-5. PubMed ID: 21534236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein glomerulopathy with a new apolipoprotein E phenotype.
    Komatsu T; Kanatsu K; Ochi H; Kita T; Doi T
    Am J Kidney Dis; 1995 Jun; 25(6):952-3. PubMed ID: 7771495
    [No Abstract]   [Full Text] [Related]  

  • 12. Lipoprotein glomerulopathy: a new apolipoprotein E mutation with enhanced glomerular binding.
    Sam R; Wu H; Yue L; Mazzone T; Schwartz MM; Arruda JA; Dunea G; Singh AK
    Am J Kidney Dis; 2006 Mar; 47(3):539-48. PubMed ID: 16490634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological and genetic characteristics in Chinese patients with lipoprotein glomerulopathy.
    Zhang B; Liu ZH; Zeng CH; Zheng JM; Chen HP; Li LS
    J Nephrol; 2008; 21(1):110-7. PubMed ID: 18264944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rare case of lipoprotein glomerulopathy in a white man: an emerging entity in Asia, rare in the white population.
    Boumendjel R; Papari M; Gonzalez M
    Arch Pathol Lab Med; 2010 Feb; 134(2):279-82. PubMed ID: 20121619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein glomerulopathy and its pathogenesis.
    Saito T; Oikawa S; Sato H; Chiba J
    Contrib Nephrol; 1997; 120():30-8. PubMed ID: 9257045
    [No Abstract]   [Full Text] [Related]  

  • 16. Apolipoprotein E (role in lipoprotein metabolism and pathophysiology of hyperlipoproteinemia type III).
    Utermann G
    Ric Clin Lab; 1982; 12(1):23-30. PubMed ID: 6283616
    [No Abstract]   [Full Text] [Related]  

  • 17. Unusual xanthomas in a young patient with heterozygous familial hypercholesterolemia and type III hyperlipoproteinemia.
    Feussner G; Dobmeyer J; Nissen H; Hansen TS
    Am J Med Genet; 1996 Oct; 65(2):149-54. PubMed ID: 8911609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Apolipoprotein E].
    Yamamura T
    Nihon Rinsho; 1994 Dec; 52(12):3124-32. PubMed ID: 7853700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoprotein glomerulopathy induced by ApoE-Sendai is different from glomerular lesions in aged apoE-deficient mice.
    Ishimura A; Watanabe M; Nakashima H; Ito K; Miyake K; Mochizuki S; Ishigaki Y; Saito T
    Clin Exp Nephrol; 2009 Oct; 13(5):430-437. PubMed ID: 19459027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New evolution in lipoprotein glomerulopathy].
    Saito T; Matsunaga A; Nakashima H
    Nihon Jinzo Gakkai Shi; 2013; 55(7):1314-9. PubMed ID: 24288968
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.